0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Vascular Dementia - Epidemiology Forecast to 2028
Published Date: April 2019
|
Report Code: DELV-Epid-448
Home | Market Reports | Health | Aging & Geriatrics
Vascular Dementia Epidemiology Forecast to 2028

Vascular Dementia - Epidemiology Forecast to 2028

Code: DELV-Epid-448
Report
April 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Vascular Dementia - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Vascular Dementia epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Vascular Dementia Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Vascular Dementia in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Vascular Dementia outlook. It also includes the explanation of changing trends of epidemiology outlining the Vascular Dementia scenario.

Vascular Dementia Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Vascular Dementia thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Vascular Dementia explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Vascular Dementia Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Vascular Dementia

Key assessments
• Patient Segmentation in Vascular Dementia
• Vascular Dementia Risk & Burden
• Factors driving growth in a specific Vascular Dementia patient population

1. Report Introduction
2. Vascular Dementia Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Vascular Dementia in 2016
2.2. Patient Share Distribution of Vascular Dementia in 2028
3. Disease Background and Overview: Vascular Dementia
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Vascular Dementia in 7MM
4.3. Total Prevalent/ Incident Patient Population of Vascular Dementia in 7MM – By Countries
5. Epidemiology of Vascular Dementia by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Vascular Dementia
5.1.3. Sub-Type Specific cases of the Vascular Dementia *
5.1.4. Sex- Specific Cases of the Vascular Dementia *
5.1.5. Diagnosed Cases of the Vascular Dementia
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Vascular Dementia
5.4.3. Sub-Type Specific cases of the Vascular Dementia *
5.4.4. Sex- Specific Cases of the Vascular Dementia *
5.4.5. Diagnosed Cases of the Vascular Dementia
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Vascular Dementia
5.5.3. Sub-Type Specific cases of the Vascular Dementia *
5.5.4. Sex- Specific Cases of the Vascular Dementia *
5.5.5. Diagnosed Cases of the Vascular Dementia
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Vascular Dementia
5.6.3. Sub-Type Specific cases of the Vascular Dementia *
5.6.4. Sex- Specific Cases of the Vascular Dementia *
5.6.5. Diagnosed Cases of the Vascular Dementia
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Vascular Dementia
5.7.3. Sub-Type Specific cases of the Vascular Dementia *
5.7.4. Sex- Specific Cases of the Vascular Dementia *
5.7.5. Diagnosed Cases of the Vascular Dementia
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Vascular Dementia
5.8.3. Sub-Type Specific cases of the Vascular Dementia *
5.8.4. Sex- Specific Cases of the Vascular Dementia *
5.8.5. Diagnosed Cases of the Vascular Dementia
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Vascular Dementia
5.9.3. Sub-Type Specific cases of the Vascular Dementia *
5.9.4. Sex- Specific Cases of the Vascular Dementia *
5.9.5. Diagnosed Cases of the Vascular Dementia
6. Unmet Needs of the Vascular Dementia
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables :

Table 1: Total Prevalent/Incident Cases of the Vascular Dementia in 7MM
Table 2: Total Prevalent/Incident Cases of the Vascular Dementia in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Vascular Dementia in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Vascular Dementia in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Vascular Dementia in United States (2016-2028)*
Table 6: Diagnosed Cases of the Vascular Dementia in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Vascular Dementia in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Vascular Dementia in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Vascular Dementia in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Vascular Dementia in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Vascular Dementia in France (2016-2028)
Table 12: Sub-Type Specific cases of the Vascular Dementia in France (2016-2028) *
Table 13: Sex- Specific Cases of the Vascular Dementia in France (2016-2028) *
Table 14: Diagnosed Cases of the Vascular Dementia in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Vascular Dementia in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Vascular Dementia in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Vascular Dementia in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Vascular Dementia in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Vascular Dementia in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Vascular Dementia in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Vascular Dementia in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Vascular Dementia in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Vascular Dementia in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Vascular Dementia in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Vascular Dementia in UK (2016-2028) *
Table 26: Diagnosed Cases of the Vascular Dementia in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Vascular Dementia in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Vascular Dementia in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Vascular Dementia in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Vascular Dementia in Japan (2016-2028)


LIst of Figures :

Figure 1: Total Prevalent/Incident Cases of the Vascular Dementia in 7MM
Figure 2: Total Prevalent/Incident Cases of the Vascular Dementia in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Vascular Dementia in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Vascular Dementia in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Vascular Dementia in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Vascular Dementia in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Vascular Dementia in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Vascular Dementia in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Vascular Dementia in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Vascular Dementia in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Vascular Dementia in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Vascular Dementia in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Vascular Dementia in France (2016-2028) *
Figure 14: Diagnosed Cases of the Vascular Dementia in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Vascular Dementia in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Vascular Dementia in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Vascular Dementia in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Vascular Dementia in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Vascular Dementia in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Vascular Dementia in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Vascular Dementia in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Vascular Dementia in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Vascular Dementia in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Vascular Dementia in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Vascular Dementia in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Vascular Dementia in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Vascular Dementia in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Vascular Dementia in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Vascular Dementia in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Vascular Dementia in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global Transthyretin amyloid cardiomyopathy ATTR CM Treatment Market Insights Forecast to 2028
Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-0N4529
Thu Apr 21 00:00:00 UTC 2022

Add to Cart

Global Dementia Care APP Market Insights Forecast to 2028
Global Dementia Care APP Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-18C1103
Fri Apr 08 00:00:00 UTC 2022

Add to Cart

Global Pelvic Floor Rehabilitation Device Market Research Report 2022
Global Pelvic Floor Rehabilitation Device Market Research Report 2022

Postpartum nonsurgical methods such as pelvic floor rehabilitation exercises can restore and exercise the muscles damaged during pregnancy and childbirth restore the contractile ability of the pelvic floor muscles and prevent urine leakage and pelvic organ bulge.Market Analysis and Insights Global Pelvic Floor Rehabilitation Device MarketDue to the COVID19 pandemic the global Pelvic Floor Rehabilitation Device market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the forecast period 20222028.

120 Pages
Type: Report
Code: QYRE-Auto-20E10212
Wed Mar 16 00:00:00 UTC 2022

Add to Cart

Global Amyloid Oligomer Market Insights Forecast to 2028
Global Amyloid Oligomer Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-31N3244
Wed Mar 09 00:00:00 UTC 2022

Add to Cart